Bhutani Hemant, Singh Saranjit, Vir Sanjay, Bhutani K K, Kumar Raj, Chakraborti Asit K, Jindal K C
Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar 160062, Punjab, India.
J Pharm Biomed Anal. 2007 Mar 12;43(4):1213-20. doi: 10.1016/j.jpba.2006.10.013. Epub 2006 Nov 21.
Isoniazid was subjected to different ICH prescribed stress conditions of thermal stress, hydrolysis, oxidation and photolysis. The drug was stable to dry heat (50 and 60 degrees C). It showed extensive decomposition under hydrolytic conditions, while it was only moderately sensitive to oxidation stress. The solid drug turned intense yellow on exposure to light under accelerated conditions of temperature (40 degrees C) and humidity (75% RH). In total, three major degradation products were detected by LC. For establishment of stability-indicating assay, the reaction solutions in which different degradation products were formed were mixed, and the separation was optimized by varying the LC conditions. An acceptable separation was achieved using a C-18 column and a mobile phase comprising of water:acetonitrile (96:4, v/v), with flow rate and detection wavelength being 0.5 ml min(-1) and 254 nm, respectively. The degradation products appeared at relative retention times (RR(T)) of 0.71, 1.34 and 4.22. The validation studies established a linear response of the drug at concentrations between 50 and 1000 microg ml(-1). The mean values (+/-R.S.D.) of slope, intercept and correlation coefficient were 35,199 (+/-0.88), 114,310 (+/-4.70) and 0.9998 (+/-0.01), respectively. The mean R.S.D. values for intra- and inter-day precision were 0.24 and 0.90, respectively. The recovery of the drug ranged between 99.42 and 100.58%, when it was spiked to a mixture of solutions in which sufficient degradation was observed. The specificity was established through peak purity testing using a photodiode array detector. The method worked well on application to marketed formulation of isoniazid, and a fixed-dose combination containing isoniazid and ethambutol HCl. It was even extendable to LC-MS studies, which were carried out to identify the three degradation products. The m/z values of the peaks at RR(T) 0.71 and RR(T) 1.34 matched with isonicotinic acid and isonicotinamide, respectively. The product appearing at RR(T) 4.22 was isolated using preparative LC-MS, and turned out to be a yellow compound that was identified as isonicotinic acid N'-(pyridyl-4-carbonyl)-hydrazide based on mass, FTIR and (1)H/(13)C NMR spectral data. The same was indicated to be responsible for discolouration of isoniazid bulk drug substance and formulations, which is a familiar problem. The mechanism of formation of the said compound is outlined.
异烟肼经受了国际协调会议(ICH)规定的不同强制降解条件,包括热应力、水解、氧化和光解。该药物对干热(50和60摄氏度)稳定。在水解条件下它显示出大量分解,而对氧化应激仅中度敏感。在温度(40摄氏度)和湿度(75%相对湿度)加速条件下,固体药物暴露于光下会变成深黄色。通过液相色谱(LC)总共检测到三种主要降解产物。为建立稳定性指示分析方法,将形成不同降解产物的反应溶液混合,并通过改变LC条件优化分离。使用C-18柱和由水:乙腈(96:4,v/v)组成的流动相实现了可接受的分离,流速和检测波长分别为0.5毫升/分钟和254纳米。降解产物出现在相对保留时间(RR(T))为0.71、1.34和4.22处。验证研究确定该药物在50至1000微克/毫升浓度之间呈线性响应。斜率、截距和相关系数的平均值(±相对标准偏差)分别为35,199(±0.88)、114,310(±4.70)和0.9998(±0.01)。日内和日间精密度的平均相对标准偏差值分别为0.24和0.90。当将该药物添加到观察到充分降解的混合溶液中时,其回收率在99.42%至100.58%之间。通过使用光电二极管阵列检测器进行峰纯度测试确定了特异性。该方法应用于市售的异烟肼制剂以及含有异烟肼和盐酸乙胺丁醇的固定剂量复方制剂时效果良好。它甚至可扩展到用于鉴定三种降解产物的LC-MS研究。相对保留时间为0.71和1.34处峰的m/z值分别与异烟酸和异烟酰胺匹配。使用制备型LC-MS分离出相对保留时间为4.22处出现的产物,结果是一种黄色化合物,根据质谱、傅里叶变换红外光谱(FTIR)和氢谱/碳谱(1H/(13)C NMR)光谱数据鉴定为异烟酸N'-(吡啶-4-羰基)-酰肼。同样表明该化合物是异烟肼原料药和制剂变色的原因,这是一个常见问题。概述了所述化合物的形成机制。